Page last updated: 2024-09-03

ms 857 and Heart Failure

ms 857 has been researched along with Heart Failure in 2 studies

*Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwase, M; Nagata, K; Sobue, T; Yokota, M1
Kaiho, T; Kamiya, J; Kobari, T; Maruyama, M1

Trials

1 trial(s) available for ms 857 and Heart Failure

ArticleYear
Differential effects of dobutamine and a phosphodiesterase inhibitor on early diastolic filling in patients with congestive heart failure.
    Journal of the American College of Cardiology, 1995, Volume: 25, Issue:2

    Topics: Administration, Oral; Blood Flow Velocity; Cardiac Catheterization; Coronary Circulation; Diastole; Dobutamine; Echocardiography, Doppler, Pulsed; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Isoquinolines; Male; Middle Aged; Phosphodiesterase Inhibitors; Tetrahydroisoquinolines; Ventricular Function, Left

1995

Other Studies

1 other study(ies) available for ms 857 and Heart Failure

ArticleYear
Cardiovascular properties of MS-857, a new and potent cardiotonic agent, on normal and failing hearts.
    Journal of cardiovascular pharmacology, 1988, Volume: 12, Issue:5

    Topics: Anesthesia; Animals; Cardiotonic Agents; Dogs; Female; Heart; Heart Failure; Isoquinolines; Lung; Male; Myocardium; Pentobarbital; Phosphoric Diester Hydrolases; Propranolol; Sodium-Potassium-Exchanging ATPase; Stereoisomerism; Tetrahydroisoquinolines

1988